Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor TrendingStockAlerts · Jan 25, 2026
Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets™ TrendingStockAlerts · Jan 24, 2026
CannaLean Biotechs Announces Positive Completion of First-in-Human Feasibility Study of Its Novel CBD-Based Lipid-Lowering Therapy TrendingStockAlerts · Jan 22, 2026
EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2 TrendingStockAlerts · Jan 21, 2026
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership TrendingStockAlerts · Jan 20, 2026
Crosswalk Therapeutics Secures National MPS Society Grant to Address Unmet Skeletal Disease in Morquio A Syndrome TrendingStockAlerts · Jan 19, 2026
Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors TrendingStockAlerts · Jan 18, 2026
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth TrendingStockAlerts · Jan 16, 2026
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program TrendingStockAlerts · Jan 15, 2026
Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight TrendingStockAlerts · Jan 14, 2026
